Clinical trial
A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Active…
NCT00036439 · Centocor, Inc., Industry · Completed
Key facts
| NCT number | NCT00036439 |
|---|---|
| Title | A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Active Ulcerative Colitis |
| Official title | A Randomized, Placebo-controlled, Double-blind Trial to Evaluate the Safety and Efficacy of Infliximab in Patients With Active Ulcerative Colitis |
| Lead sponsor | Centocor, Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Ulcerative Colitis |
| Intervention type | Drug |
| Interventions | Infliximab |
| Enrollment | 364 |
| Start date | Feb 1, 2002 |
| Completion | Jan 1, 2007 |
| First posted | May 13, 2002 |
| Last update posted | May 17, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: